Eleanor is an Associate at Thuja Capital, where she leads due diligence efforts on new investment opportunities and supports active portfolio management. Prior to joining Thuja in 2022, she was a Consultant at IQVIA, where she focused on commercial strategy for pharmaceutical products and due diligence to support private equity investments in healthcare. She previously led the operations of a biotech accelerator, PanaceaStars, based in Oxford UK. Eleanor holds a BSc in Cellular and Molecular Medicine (University of Bristol), a PhD in Cardiovascular Regenerative Medicine (University of Oxford) and an MBA (Quantic School of Business and Technology).